TY - JOUR AU - Schuller, Hildegard M. PY - 2018 TI - Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer JF - Translational Lung Cancer Research; Vol 7, Supplement 2 (April 23, 2018): Translational Lung Cancer Research Y2 - 2018 KW - N2 - Non-small cell lung cancer (NSCLC) is a family of cancers comprised of four different histological subtypes: adenocarcinoma, squamous cell carcinoma, large cell carcinoma and carcinoids. Among the NSCLC subtypes, adenocarcinoma is the most common with incidence rising (1). UR - https://tlcr.amegroups.org/article/view/20237